hotspot -WSS

hotspot

author：comprehensive 2025-10-01 10:33:27 - browse：811

Sen. Ron Wyden, D-Ore., left, and Sen. Mike Crapo, R-Idaho, right, walk on Capitol Hill. -- health policy coverage from STAT — Sen. Ron Wyden, D-Ore., left, and Sen. Mike Crapo, R-Idaho, right, walk on Capitol Hill in 2021. Susan Walsh/AP

WASHINGTON — One of the top health care committees in the Senate is assembling ideas for bipartisan legislation to address drug shortages, three Senate aides and three lobbyists told STAT.

The talks, led by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho) are in the early days, but they could move the debate over drug shortage reforms into a new phase. The committee has jurisdiction over Medicare and Medicaid payment policies for hospitals. Other committees that have tried tackling the issue have jurisdiction mostly over the Food and Drug Administration.

The panel is tentatively aiming to hold a hearing on the issue in November, the sources said. The panel has also started accepting input from outside stakeholders, one lobbyist said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： EpiPen alternative approval delay highlights citizen petition issue

hotspot

WSS

CDC advisers recommend seasonal use of Pfizer RSV shot

How to protect coverage of PrEP

FAMU bans football players from facility after release of rap video shot in team's locker room

Microbiome research is starting to find links to chronic diseases

Emergency workers more likely to restrain Black patients: study

Readout LOUD podcast: possible new ALS drug, artificial wombs

entertainment

hotspot

explore

Trump demands the U.S. pay no more for drugs than other countries … again

Senate HELP committee spars over health care workforce policies

Alkermes shareholders re

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

Continuity nursing helped my family in our darkest PICU moments

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

What does generative AI mean for health care? We asked experts

Intarcia’s device

The cancer drug shortage isn’t new — and neither are the solutions

Men with early prostate cancer can safely opt out of treatment

hotspot

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

CDC's new outbreak response network to include Northeastern

Hearing on Medicare drug price negotiation gets unusually heated

Changes to biosimilar regulatory framework must prioritize patients

FDA approves first blood sugar monitor without finger pricks

Ukraine and a new approach to mental health in war

knowledge

hotspot

Wikipedia

hotspot